Your reply here actually illustrates the major, crippling problems caused by CEO M's distaste for broad shareholder communication. There's a lot of misinformation, late information or no information but never, ever any honest communication with shareholders.
The test referred to in Stock Bro's message is, by the looks of it, a new test for ABMC. It is for Covid and Flu and it is manufactured in New Jersey by Princeton Bio Meditech Corporation.
I assume, based on SB's message, that ABMC is now selling that test but it is not on the ABMC website and has not yet been PR'ed.
The test you refer to is, according to the 10K, not sold in the USA at his time. From the 10K:
"The Rapid Covid-19 Antigen Test Cassette we began distributing in December 2020 is currently being marketed to only locations outside the United States"
Now I don't fault you or anyone else for not knowing these things but we should know these things. I sure didn't know myself until I read the 10k, but it's now some months after the fact. There should be a better working knowledge of this company that is widely disseminated. That's called guidance. The CEO seems to think keeping your shareholders up to date is the same as touting.
Cheers
News 
Market Data 
Discover 
AI
